Reproductive issues in sickle cell disease

Blood - Tập 124 - Trang 3538-3543 - 2014
Kim Smith-Whitley1
1Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA

Tóm tắt

Abstract As medical advances improve survival, reduce disease-related morbidity, and improve quality of life, reproductive issues will take higher priority in the sickle cell disease (SCD) community. A wide variety of topics are addressed in this chapter, including fertility, gonadal failure, erectile dysfunction, and menstrual issues in SCD. Etiologies of impaired male fertility are multifactorial and include hypogonadism, erectile dysfunction, sperm abnormalities, and complications of medical therapies. Much less is known about the prevalence and etiology of infertility in women with SCD. Other reproductive issues in women included in this review are pain and the menstrual cycle, contraception, and preconception counseling. Finally, long-term therapies for SCD and their impact on fertility are presented. Transfusional iron overload and gonadal failure are addressed, followed by options for fertility preservation after stem cell transplantation. Focus is placed on hydroxyurea therapy given its benefits and increasing use in SCD. The impact of this agent on spermatogenesis, azoospermia, and the developing fetus is discussed.

Tài liệu tham khảo

Luban, 1982, Growth and development in sickle cell anemia: preliminary report., Am J Pediatr Hematol Oncol, 4, 61 Zemel, 2007, Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease., Pediatr Res, 61, 607, 10.1203/pdr.0b013e318045bdca Taddesse, 2012, Hypogonadism in patients with sickle cell disease: central or peripheral?, Acta Haematol, 128, 65, 10.1159/000337344 Dada, 1980, Endocrine function and haemoglobinopathies: relation between the sickle cell gene and circulating plasma levels of testosterone, luteinising hormone (LH) and follicle stimulating hormone (FSH) in adult males., Clin Chim Acta, 105, 269, 10.1016/0009-8981(80)90469-6 Osegbe, 1987, Testicular dysfunction in men with sickle cell disease., Postgrad Med J, 63, 95, 10.1136/pgmj.63.736.95 Parshad, 1994, The mechanism of low testosterone levels in homozygous sickle-cell disease., West Indian Med J, 43, 12 Abbasi, 1976, Gonadal function abnormalities in sickle cell anemia: studies in adult male patients., Ann Intern Med, 85, 601, 10.7326/0003-4819-85-5-601 el-Hazmi, 1992, Endocrine functions in sickle cell anaemia patients., J Trop Pediatr, 38, 307, 10.1093/tropej/38.6.307 Modebe, 1995, Effect of age on testicular function in adult males with sickle cell anemia., Fertil Steril, 63, 907, 10.1016/S0015-0282(16)57500-1 Prasad, 1981, Zinc deficiency in human subjects., Prog Clin Biol Res, 77, 165 Li, 2003, Repeated testicular infarction in a patient with sickle cell disease: a possible mechanism for testicular failure., Urology, 62, 551, 10.1016/S0090-4295(03)00482-5 Morrison, 2013, Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report., Andrology, 1, 576, 10.1111/j.2047-2927.2013.00084.x Landefeld, 1983, Clomiphene-responsive hypogonadism in sickle cell anemia., Ann Intern Med, 99, 480, 10.7326/0003-4819-99-4-480 Berthaut, 2008, Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males., Haematologica, 93, 988, 10.3324/haematol.11515 Nahoum, 1980, Semen analysis in sickle cell disease., Andrologia, 12, 542, 10.1111/j.1439-0272.1980.tb01347.x Osegbe, 1981, Fertility in males with sickle cell disease., Lancet, ii, 275, 10.1016/S0140-6736(81)90525-0 Friedman, 1974, Testicular function in sickle cell disease., Fertil Steril, 25, 1018, 10.1016/S0015-0282(16)40809-5 Adeyoju, 2002, Priapism in sickle-cell disease; incidence, risk factors and complications-an international multicentre study., BJU Int, 90, 898, 10.1046/j.1464-410X.2002.03022.x Emond, 1980, Priapism and impotence in homozygous sickle cell disease., Arch Intern Med, 140, 1434, 10.1001/archinte.1980.00330220022011 Madu, 2014, Priapism in homozygous sickle cell patients: important clinical and laboratory associations., Med Princ Pract, 23, 259, 10.1159/000360608 Bertram, 1985, Implantation of penile prostheses in patients impotent after priapism., Urology, 26, 325, 10.1016/0090-4295(85)90176-1 Douglas, 1990, Penile prostheses in the management of impotence in sickle cell disease., Br J Urol, 65, 533, 10.1111/j.1464-410X.1990.tb14803.x Jimenez, 1966, Studies in sickle cell anemia XXVI. The effect of homozygous sickle cell disease in the onset of menarche, pregnancy, fertility, pubescent changes and body growth in Negro subjects., Am J Dis Child, 111, 497, 10.1001/archpedi.1966.02090080075005 Alleyne, 1981, Sexual development and fertility of Jamaican female patients with homozygous sickle cell disease., Arch Intern Med, 141, 1295, 10.1001/archinte.1981.00340100051014 Dunne, 1970, Fertility in hemoglobin S-S and hemoglobin S-C disease., Fertil Steril, 21, 630, 10.1016/S0015-0282(16)37688-9 Samuels-Reid, 1984, Contraceptive practices and reproductive patterns in sickle cell disease., J Natl Med Assoc, 76, 879 Samuels-Reid, 1985, Painful crises and menstruation in sickle cell disease., South Med J, 78, 384, 10.1097/00007611-198504000-00007 Westerman, 1997, Assessment of painful episode frequency in sickle-cell disease., Am J Hematol, 54, 183, 10.1002/(SICI)1096-8652(199703)54:3<183::AID-AJH2>3.0.CO;2-S Yoong, 2002, Menstrual pattern in women with sickle cell anaemia and its association with sickling crises., J Obstet Gynaecol, 22, 399, 10.1080/01443610220141362 Isaacs, 1972, Steroid treatment in the prevention of painful episodes in sickle-cell disease., Lancet, i, 570, 10.1016/S0140-6736(72)90359-5 Chavis, 1993, Sexuality and sickle cell disease., J Natl Med Assoc, 85, 113 Côbo, 2013, Sexuality and sickle cell anemia., Rev Bras Hematol Hemoter, 35, 89, 10.5581/1516-8484.20130027 Smith, 2012, Reproductive attitudes and behaviors in people with sickle cell disease or sickle cell trait: a qualitative interpretive emeta-synthesis., Soc Work Health Care, 51, 757, 10.1080/00981389.2012.693580 Pickle, 2014, Prevention of unintended pregnancy: a focus on long-acting reversible contraception., Prim Care, 41, 239, 10.1016/j.pop.2014.02.004 Samuels-Reid, 1984, Contraceptive practices and reproductive patterns in sickle cell disease., J Natl Med Assoc, 76, 879 Howard, 1993, Contraceptives, counselling, and pregnancy in women with sickle cell disease., BMJ, 306, 1735, 10.1136/bmj.306.6894.1735 Knight-Madden, 2009, Contraceptive usage among Jamaican women with sickle cell disease., Contraception, 80, 474, 10.1016/j.contraception.2009.05.121 Okunlola, 2010, Pattern of contraceptive use among women with sickle cell disease in Ibadan, South-west Nigeria., J Obstet Gynaecol, 30, 171, 10.3109/01443610903452799 O'Brien, 2011, Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims., Contraception, 83, 134, 10.1016/j.contraception.2010.06.017 Eissa, Trends in family planning and counselling for women with sickle cell disease in the UK over two decades [published online ahead of print May 23, 2014]., J Fam Plann Reprod Health Care Freie, 1983, Sickle cell diseases and hormonal contraception., Acta Obstet Gynecol Scand, 62, 211, 10.3109/00016348309155794 Lutcher, 1981, A lack of morbidity from oral contraception in women with sickle cell anemia [abstract]., Clin Res, 29, 863A Lutcher, 1986, Contraceptive-induced vascular occlusive events in sickle cell disorders-fact or fiction? [abstract]., Clin Res, 34, 217A de Abood, 1997, Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients., Contraception, 56, 313, 10.1016/S0010-7824(97)00156-X De Ceulaer, 1982, Medroxyprogesterone acetate and homozygous sickle-cell disease., Lancet, ii, 229, 10.1016/S0140-6736(82)90320-8 Barbosa, 2001, Carbohydrate metabolism in sickle cell patients using a subdermal implant containing nomegestrol acetate (Uniplant)., Contraception, 63, 263, 10.1016/S0010-7824(01)00202-5 Nascimento, 1998, Nomegestrol acetate contraceptive implant use by women with sickle cell disease., Clin Pharmacol Ther, 64, 433, 10.1016/S0009-9236(98)90074-1 ACOG Committee on Practice Bulletins-Gynecology, 2006, ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions., Obstet Gynecol, 107, 1453, 10.1097/00006250-200606000-00055 Centers for Disease Control and Prevention, 2010, U.S. Medical Eligibility Criteria for Contraceptive Use, 2010., MMWR Recomm Rep, 59, 1 Michlitsch, 2008, Recent advances in bone marrow transplantation in hemoglobinopathies., Curr Mol Med, 8, 675, 10.2174/156652408786241393 Bhatia, 2008, Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future., Bone Marrow Transplant, 41, 109, 10.1038/sj.bmt.1705943 Lucarelli, Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia [published online ahead of print July 28, 2014]., Bone Marrow Transplant Walters, 2010, Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease., Biol Blood Marrow Transplant, 16, 263, 10.1016/j.bbmt.2009.10.005 Donnez, 2011, Live birth after allografting of ovarian cortex between genetically non-identical sisters., Hum Reprod, 26, 1384, 10.1093/humrep/der089 Hsieh, 2009, Allogeneic hematopoietic stem-cell transplantation for sickle cell disease., N Engl J Med, 361, 2309, 10.1056/NEJMoa0904971 Hsieh, 2014, Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype., JAMA, 312, 48, 10.1001/jama.2014.7192 Krishnamurti, 2008, Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease., Biol Blood Marrow Transplant, 14, 1270, 10.1016/j.bbmt.2008.08.016 Smiers, 2010, Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends., Pediatr Clin North Am, 57, 181, 10.1016/j.pcl.2010.01.003 Gharwan, 2014, Successful fertility restoration after allogeneic hematopoietic stem cell transplantation., Endocr Pract, 20, e157, 10.4158/EP13474.CR Dovey, 2012, Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report., J Assist Reprod Genet, 29, 265, 10.1007/s10815-011-9698-2 Roux, 2010, Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation., Fertil Steril, 93, 2413.e15, 10.1016/j.fertnstert.2009.12.022 Donnez, 2011, Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births., Ann Med, 43, 437, 10.3109/07853890.2010.546807 Ginsberg, 2014, Testicular tissue cryopreservation in prepubertal male children: an analysis of parental decision-making., Pediatr Blood Cancer, 61, 1673, 10.1002/pbc.25078 Jadoul, 2010, Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed?, Hum Reprod Update, 16, 617, 10.1093/humupd/dmq010 Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology, 2013, Mature oocyte cryopreservation: a guideline., Fertil Steril, 99, 37, 10.1016/j.fertnstert.2012.09.028 Practice Committee of American Society for Reproductive Medicine, 2014, Ovarian tissue cryopreservation: a committee opinion., Fertil Steril, 101, 1237, 10.1016/j.fertnstert.2014.02.052 Somigliana, Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation [published online ahead of print July 10, 2014]., Hum Reprod Update Quinn, 2012, Preserving the right to future children: an ethical case analysis., Am J Bioeth, 12, 38, 10.1080/15265161.2012.673688 Fung, 2007, Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload., Am J Hematol, 82, 255, 10.1002/ajh.20809 Fung, 2006, Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease., Br J Haematol, 135, 574, 10.1111/j.1365-2141.2006.06332.x Singer, 2011, Reproductive capacity in iron overloaded women with thalassemia major., Blood, 118, 2878, 10.1182/blood-2011-06-360271 Charache, 1995, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia., N Engl J Med, 332, 1317, 10.1056/NEJM199505183322001 de Montalembert, 1997, Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease., J Pediatr Hematol Oncol, 19, 313, 10.1097/00043426-199707000-00009 Wang, 2011, Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)., Lancet, 377, 1663, 10.1016/S0140-6736(11)60355-3 Wang, 2002, Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study., J Pediatr, 140, 225, 10.1067/mpd.2002.121383 National Toxicology Program, 2008, NTP-CERHR monograph on the potential human reproductive and developmental effects of hydroxyurea., NTP CERHR Mon, 21, vii Strouse, 2008, Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children., Pediatrics, 122, 1332, 10.1542/peds.2008-0441 Lanzkron, 2008, Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease., Ann Intern Med, 148, 939, 10.7326/0003-4819-148-12-200806170-00221 Shin, 1999, Involvement of germ cell apoptosis in the induction of testicular toxicity following hydroxyurea treatment., Toxicol Appl Pharmacol, 155, 139, 10.1006/taap.1998.8593 Jones, 2009, Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility end points., Int J Environ Res Public Health, 6, 1124, 10.3390/ijerph6031124 Garozzo, 2000, Azoospermia in a patient with sickle cell disease treated with hydroxyurea., Haematologica, 85, 1216 Grigg, 2007, Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease., Intern Med J, 37, 190, 10.1111/j.1445-5994.2006.01290.x Lukusa, 2008, Use of hydroxyurea from childhood to adult age in sickle cell disease: semen analysis., Haematologica, 93, e67, 10.3324/haematol.13659 Lukusa, 2009, Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles., Pediatr Hematol Oncol, 26, 186, 10.1080/07357900902892780 Brawley, 2008, National Institutes of Health Consensus Development Conference Statement: hydroxyurea treatment for sickle cell disease., Ann Intern Med, 148, 932, 10.7326/0003-4819-148-12-200806170-00220 Saleh, 2014, Leukemia during pregnancy: long term follow up of 32 cases from a single institution., Hematol Oncol Stem Cell Ther, 7, 63, 10.1016/j.hemonc.2014.03.001 Ballas, 2009, Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia., J Natl Med Assoc, 101, 1046, 10.1016/S0027-9684(15)31072-5 Italia, 2010, Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases., J Clin Pharmacol, 50, 231, 10.1177/0091270009343933